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Abstract: Compounds tested during drug development may have adverse 
effects on the heart; therefore all new chemical entities have to undergo 
extensive preclinical assessment for cardiac liability. Conventional 
intensity-based imaging techniques are not robust enough to provide 
detailed information for cell structure and the captured images result in low-
contrast, especially to cell with semi-transparent or transparent feature, 
which would affect the cell analysis. In this paper we show, for the first 
time, that digital holographic microscopy (DHM) integrated with 
information processing algorithms automatically provide dynamic 
quantitative phase profiles of beating cardiomyocytes. We experimentally 
demonstrate that relevant parameters of cardiomyocytes can be obtained by 
our automated algorithm based on DHM phase signal analysis and used to 
characterize the physiological state of resting cardiomyocytes. Our study 
opens the possibility of automated quantitative analysis of cardiomyocyte 
dynamics suitable for further drug safety testing and compounds selection as 
a new paradigm in drug toxicity screens. 
2015 Optical Society of America 
OCIS codes: (090.1995) Digital holography; (100.6890) Three-dimensional image processing; 
(170.3880) Medical and biological imaging; (170.1530) Cell analysis; (999.9999) Quantitative 
phase microscopy; (999.9999) Cardiomyocyte; (999.9999) Cardiotoxicity; (999.9999) High 
content screening.  
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1. Introduction  
During the lengthy drug discovery process, it is crucial to improve the predictability of 
compound toxicity through safety profiling assays. This is done in order to detect potentially 
toxic compounds early in the process before significant time and important financial 
investments are made. Between 1994 and 2006, 38 of the new drugs approved by the US Food 
and Drug Administration (FDA) were later withdrawn from the market because of safety 
concerns, the majority being cardiotoxic or hepatotoxic [1]. Safety assessments are therefore 
performed in preclinical drug development for revealing possible drug side effects in 
particular those that may affect the electrical conduction and beating of the heart [2-6]. 
Therefore, researchers and pharmaceutical companies have to ensure that the effect of lead 
candidate compounds on cardiac function strictly satisfy safety criteria. Consequently, it is 
critical to establish more informative in vitro cardiotoxicity screens and data analysis 
algorithms at the early phases of drug development for preventing late stage failure [7-9].  
Cardiomyocytes or myocardial cells are the main contractile elements of the heart muscle. 
These cells work cooperatively to generate human heart beating and control blood flow 
through the blood vessels of the circulatory system [6]. Like many other types of biological 
cells, cardiomyocytes are mostly transparent. As a result, conventional two-dimensional (2D) 
imaging systems based solely on the intensity of bright-field only generate a low contrast 
captured image with limited informative details on the cell structure. Even though some 
optical imaging techniques, such as phase contrast and differential interference contrast 
microscopies, can generate contrast from transparent cells, they cannot provide quantitative 
information about their thickness. 
Various imaging systems have been previously used to study cardiomyocytes. For instance 
with fluorescence microscopy [10-11], specific biological molecules can be fluorescently 
stained and the location of a protein can be traced or the activity of a specific ions can be 
monitored in time [12-13]. However fluorescence can fade or interfere with the measured 
molecule [14-15]. Atomic force microscopy [16] allows measuring advanced physical 
mechanical parameters like stiffness and elastic modulus in addition to a high resolution 
profile of the sample [17], but has a limited spatial sampling speed. DIC and Phase Contrast 
have been used to monitor isolated cardiomyocyte contraction non-invasively but through the 
use of advanced image correlation analysis [18]. Each of these techniques has their own 
advantages and limitation and together provides complementary information that can be 
exploited in multimodal setups [19]. 
In the present article, the dynamic quantitative phase profiles of beating cardiomyocytes, 
which are proportional to the optical path delay profile of the cell, are reconstructed from 
holograms that are captured through digital holographic microscopy (DHM) [20-23]. The 
beating activities of cardiomyocytes, and contraction and relaxation profiles are derived from 
the reconstructed quantitative phase image. In addition, other characteristic parameters used to 
categorize phenotypes [3, 24] such as rising time, falling time, peak width, and frequency are 
analyzed. These parameters are valuable for the analysis of drug candidates’ effects on 
cardiomyocytes. Other techniques usually rely on thresholding, derivative and curve fitting 
techniques to acquire the aforementioned parameters [3, 9]. 
In the present work, we analyze the dynamic beating profile of cardiomyocytes obtained by 
DHM using two proposed methods, either by monitoring the average or the variance 
information of imaged cells. We also quantify contraction and relaxation movement by 
analyzing the difference between two successively acquired DHM quantitative phase images. 
From our experimental results, we propose automated procedures for multiple parameters 
recording on cardiomyocytes dynamics imaged by DHM for a new methodology in drug 
toxicity screens. 
2. Materials and Methods 
2.1 Cell Culture and Imaging 
iCell cardiomyocytes (human induced pluripotent stem (iPS) cell-derived cardiomyocytes) 
obtained for Cellular Dynamics Int. (Madison, WI) were culture according to the 
manufacturer’s indication and grown for 14 days before recording. Measurements were 
achieved in a Chamlide WP incubator system for 96-well plate (LCI, South Korea) set at 
37°/5% C02 with high humidity.  
DHM images were acquired in an off-axis configuration on a commercially available DHM T-
1001 from LynceeTec SA (Lausanne, Switzerland) equipped with a motorized xy stage 
(Märzhäuser Wetzlar GmbH & Co. KG, Wetzlar, Germany, ref. S429). Images were recorded 
using a Leica 20×/0.4 NA objective (Leica Microsystems GmbH, Wetzlar, Germany, ref. 
11566049). Time-lapse images were acquired at 10 Hz for 1 minute. 
2.2 Label-free Digital Holographic Imaging 
DHM has been studied for applications in the field of cell biology, including automated cell 
counts, recognition, classification, three-dimensional tracking, and discrimination between 
physiological and pathophysiological states [25-32]. Briefly, DHM [20-23] is a label-free 
interferometric microscopy technique which provides a quantitative measurement of the 
optical path length. It is a two-step process where a hologram consisting of an interference 
pattern is first recorded on a digital camera and the quantitative phase images are 
reconstructed numerically using a specific algorithm [20]. With current computer power, the 
reconstruction process can be achieved on-the-fly at a speed of 100 image reconstruction per 
second. The quantitative phase images are related to the optical path difference (OPD), 
expressed in terms of physical properties as: 
[ ]( , ) ( , ) ( , )c mOPD x y d x y n x y n= × − ,                       (1) 
where d(x,y) is the cell thickness, nc(x,y) is the mean intracellular refractive index integrated 
along the optical axis at the (x,y) position and nm is the refractive index of the surrounding 
culture medium. Simply, Eq (1) means that the OPD signal is proportional to both the cell 
thickness and the intracellular refractive index, a property linked to the protein and water 
content of the cells [33-35]. DHM systems generally use a low intensity laser as a light source 
for specimen illumination and a digital camera to record the hologram. Here, the 684 nm laser 
source delivers roughly 200 μW/cm2 at the specimen plane — that is some six orders of 
magnitude less than intensities typically associated with confocal fluorescence microscopy. 
With that amount of light, the exposure time is only 400 μs. An extensive quality control of 
DHM can be found in [36]. The schematic of the off-axis DHM is shown in Fig. 1. 
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Fig. 1. The schematic of the off-axis digital holographic microscopy (DHM). 
 
3. Automated Multi-Parameter Measurement on Cardiomyocytes Dynamics using DHM 
For the quantitative analysis of cardiomyocyte dynamics, we calculated the beating activity 
using two alternative methods, averaged optical path difference (OPD) images and variance of 
OPD images. The contraction and relaxation feature of cardiomyocyte were also measured 
using the proposed automated procedure. Figure 2 shows two OPD images of cardiomyocytes 
reconstructed from holograms. The high similarity between the two images highlights the 
need for advanced analysis to quantify the beating dynamics. 
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Fig. 2. The optical path difference (OPD) [nm] images of cardiomyocytes captured at different 
times (among total 540 frames). (a) Cardiomyocyte OPD image at the minimum of peaks. (b) 
Cardiomyocyte OPD image at the maximum of peaks. (c) The difference image between (a) 
and (b). 
 
Fig. 3. Threshold cardiomyocyte image (red color denotes background after thresholding).  
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Fig. 4. Beating activity of cardiomyocyte (inset shows a single beat). 
 
3.1 Cardiomyocytes Beating Profile Measurement using Averaged OPD Images  
The beating profile of cardiomyocytes was briefly calculated by thresholding the 
cardiomyocyte OPD images with a threshold value of 10% of the maximum OPD signal and 
then the thresholded images were averaged. The threshold value is used to restrain the effect 
of noise. This process is described by the following equation:  
( ) ( )
( ) ( ) ( )
( )
( ) ( )
= ( _ ( , ) ) ,
( , ) ( , ) max( ( , ) ) 0.10
_ ( , )
0 ( , ) max( ( , ) ) 0.10
i i
i i i
i
i i
opd average opd thresh x y
opd x y if opd x y opd x y
with opd thresh x y
if opd x y opd x y
 ≥ ×
= 
< ×
    (2) 
where 
( )i
opd is the average value of ith OPD image after thresholding, opd_thresh(x,y)(i) is the 
OPD value at location of (x,y) on the ith thresholded cardiomyocyte image, opd(x,y) is the 
OPD value at location of (x,y) for the ith cardiomyocyte image in optical path difference while 
1≦x≦M, 1≦y≦N (M and N are the size of cardiomyocyte OPD image), max(opd(x,y))(i) means 
the maximum value of the ith cardiomyocyte image. One of the thresholded cardiomyocyte 
images obtained with this method is given in Fig. 3. In addition, the beating profile with the 
capture time of cardiomyocytes resulted from this method is showed in Fig. 4 including a 
small inset with a zoom on a single beating pattern. It is noted that the beating activity of 
cardiomyocytes is obvious (short peaks of high amplitude). Moreover, the beating activity of 
cardiomyocytes with different threshold settings is presented in Fig. 5. It can be seen from Fig. 
5 that the beating profiles of cardiomyocytes are approximately the same even though the 
resulted OPD values are a slightly different. However, it can be expected that the final results 
will be very similar because the multiple parameters we want to measure only depend on the 
beating profile of cardiomyocytes [see Table 1 and Fig. 7]. Since these beating profiles under 
different threshold values are similar, the values of multiple parameters will be also similar. In 
other words, changing the threshold value will not strongly affect the final parameter data.   
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Fig. 5. Beating activity of cardiomyocyte under different threshold values. 
 
Then, multiple parameters including amplitude, rising time, falling time, IBD50, IBD10, 
rising/falling slope, beating rate and beating period based on beating profile in Fig. 4 were 
derived. These parameters are described in Table 1 [2]. 
 
Table 1. Characteristic Parameters of Cardiomyocyte. 
Parameter Definition 
Amplitude Value difference from each positive peak to the following negative peak (Amplitude=Ampmax – Ampmin) [see Fig. 7] 
Rising time The time elapsed from Amp20 to Amp80 (=T3–T1) [see Fig. 7] 
Falling time The time elapsed from Amp80 to Amp20 (=T6–T4)[see Fig. 7] 
IBD50 The time elapsed for two points compose one Amp50 (=T5–T2) [see Fig. 7] 
IBD10 The time elapsed for two points compose on Amp10 (=T7–T0) [see Fig. 7] 
Rising/ 
Falling slope 
The change of increased/decreased amplitude over the time course between 
Amp80 and Amp20 (=Amp80 – Amp20) [see Fig. 7] 
Beating rate The total number of positive/negative peaks in 1 minute  (= total number of positive peaks/total time) 
Beating 
period 
The time between two adjacent positive and/or negative peaks  
(= the time of ith positive peak – the time of (i-1)th positive peak) 
Frequency The number of beating period per second  (= total number of beating period/total time) 
In order to measure the above-defined parameters, peaks are detected by applying the first 
derivative technique to the original data curve in Fig. 4 and finding locations where the first 
derivative values are zeros. The detected peaks based on cardiomyocytes beating profile are 
given in Fig. 6(a). 
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Fig. 6. Detected peaks in beating profile of cardiomyocytes.  
(a) Detected peaks on raw data. (b) Filtered peaks based on results of (a). 
 
It can be noted from Fig. 6(a) that many peaks including false peaks are detected. As a sorting 
process, positive peaks with values below a threshold and the negative peaks with values 
above a threshold are removed. This threshold can be automatically determined with Otsu’s 
method [37] by using all of the positive peaks detected in Fig. 6(a). In addition, the minimum 
negative peak between two neighbor positive peaks is extracted and then the maximum 
positive peak between two neighboring negative peaks is selected. This process reduces some 
inappropriate peaks and results in appropriate peaks for each beating period as shown in Fig. 
6(b). 
Consequently, the beating profile between two adjacent negative peaks considered as one 
beating period is extracted [see Fig. 7]. It is noted that the beating periods calculated between 
two negative peaks is approximately equal to that between two positive peaks. At the same 
time, the extracted beating profile for each beating period can be fitted with polynomials of 
degree 9 in a least-square criterion. The degree of 9 is reached by examining polynomials of 
up to degree 9 (up to degree 9 because data samples among some beating profiles are around 
10) for fitting the data based on the final fitting errors. The fitted polynomial with degree of 9 
is described with the following equation:  
10
10
1
( ) ii
i
f x a x −
=
= ∑ ,                              (3) 
where x represents the sample point on each beating period and ai which is the coefficient of 
polynomial are obtained with least-square criterion based on sample points. The average 
absolute error for each sample point (absolute error between actual and fitted point) is 
measured to be 0.19. One of the fitting polynomial curves and the measured parameters are 
given in Fig. 7. 
With the fitted polynomials curves, the amplitude value defined in Table 1 can be calculated 
as the maximum value minus the minimum value on the fitted curve. Thus, the corresponding 
time (unit is second) in x axis for Amp10, Amp20, Amp50, Amp80 [see Fig. 7] can be also 
computed by solving the fitted polynomial equation. Then, all of the above mentioned 
parameters are measured for each individual beating period and a population average with 
coefficient of variation, (cv=standard deviation/average value, a parameter often used in high-
throughput screening) is computed as shown in Table 2. The pre-mentioned values of multiple 
parameters are measured based on fitting a curve between two negative peaks as it allows to 
isolate a full beating pattern and better fit rising/falling time and amplitude, also IBD can only 
be measured if a full beat is present in the analyzed period. However, as shown in Fig. 5, the 
detected positive peaks tend to be more stable and less noisy, thus we also measured the 
beating period defined as the time between two adjacent positive peaks and found similar 
results (2.93/(sd=0.10 seconds), compared to 2.94/0.10 seconds).  
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Fig. 7. Illustration of the fitted curves with parameters within one beating period on 
cardiomyocytes beating profile. 
 
Table 2. Measured Values for Multiple Parameters on Cardiomyocytes Beating Profile. 
Multi-parameter Values (mean/cv) 
1: Amplitude: 2.05/0.30 
2: Rising time: 0.58/1.05 (seconds) 
3: Falling time: 0.86/0.69 (seconds) 
4: IBD50: 0.79/0.33 (seconds) 
5: IBD10: 2.94/0.19 (seconds) 
6: Rising/Falling slope: 1.19/0.30 
7: Beating rate: 21.86/0 
8: Beating period: 2.94/(sd=0.10 seconds) 
9: Frequency 0.34/0 
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Fig. 8. Measured beating profile with variance information (inset shows a single beat). 
 
3.2 Cardiomyocytes Beating Profile Measurement using Variance of OPD Images 
An alternative way to derive the beating profile of cardiomyocytes which is less sensitive to 
noise (originating from shot noise, speckle and contribution of out-of-focus structures), but 
requires more computer resources is to measure the variance of each OPD image after the 
temporal mean of the image stack is subtracted. This method is illustrated by Eq. (4): 
( ) ( )
opd ( , )
i i
tempvariance opd x y opdδ  = −  ,                       (4) 
where opd(x,y)(i) is the ith OPD image, while 1≦x≦M and 1≦x,y≦N (M and N are the size of 
cardiomyocyte OPD image), ( )opd
iδ  represents the variance of the ith cardiomyocyte image 
after temporal mean subtracted and tempopd  is the temporal mean which is calculated as the 
mean value of the image stack in the temporal dimension. The beating profile measured with 
this method is showed in Fig. 8. Compared to the previous analysis method (Fig. 6), this 
approach is more stable and less sensitive to noise (changes in the absolute value of the OPD 
signal). 
Similar with the previous method, the peaks in Fig. 8 can be detected using the first derivative 
property [see Fig. 9(a)]. In addition, the positive and negative peaks are screened with a 
threshold value obtained by Otsu’s method [37]. Consequently, the minimum negative peak 
between two neighboring positive peaks and the maximum positive peak between two 
neighboring negative peaks are selected [see Fig. 9(b)]. 
The beating profile within one beating period (between two negative peaks) can be 
individually extracted and is fitted with polynomial equation of degree 9 in a least-square 
error sense as that in Fig. 7. The average absolute error for each sample point is measured to 
be 2.0359. Consequently, the same parameters as in the previous method can be measured and 
the corresponding mean and coefficient of variation (cv) are given in Table 3. The measured 
parameters are in excellent agreement with the literature [15].  
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Fig. 9. Detected peaks on cardiomyocyte beating profile. (a) Detected multiple peaks. (b) 
Detected multiple peaks with some false peaks removed.  
 
Table 3. Measured Multiple Parameter on Cardiomyocyte Beating Profile. 
Multi-parameter Values (mean/cv) 
1: Amplitude: 23.06/0.17 
2: Rising time: 0.45/0.98 (seconds) 
3: Falling time: 0.26/1.04 (seconds) 
4: IBD50: 0.66/0.23 (seconds) 
5: IBD10: 2.30/0.25(seconds) 
6: Rising/Falling slope: 13.83/0.17 
7: Beating rate: 21.91/0 
8: Beating period: 2.93/(sd=0.10) 
9: Frequency 0.34/0 
 
3.3 Cardiomyocytes Contraction and Relaxation Measurement 
In order to observe the contraction and relaxation feature of cardiomyocyte, each captured 
image in the temporal stack is subtracted from the following one and then the spatial variance 
of the OPD is measured thus quantifying the amount of spatial displacement between 
successive frames (the cells used here are the same as those showed in Fig. 2). The resulting 
image contains cardiomyocytes contraction and relaxation information (both indicated by an 
increase in the temporal variance signal). Two of the subtracted images are shown in Fig. 10 
where Figs. 10(a) and 10(b) are different images at the minimum and maximum of a beat, 
respectively. The beating profile with contraction and relaxation information of 
cardiomyocyte is given in Fig. 11(a), where one higher peak is for contraction and the 
neighboring lower peak is for relaxation. Then, the peaks can be detected with the first 
derivative criterion (locations where the first derivative values are zeros). Similarly, positive 
peaks for contraction can be properly extracted with Otsu’s thresholding algorithm by using 
all of the detected positive peaks. Next, a maximum peak between two neighboring 
contraction peaks is chosen as a positive peak for relaxation. Consequently, the inappropriate 
peaks can be removed. The resulted curves from Fig. 11(a) with peaks indicated are given in 
Fig. 11(b).  
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Fig. 10. Illustration of the difference images. (a) Different image at the minimum of a beat. (b) 
Different image at the maximum of a beat. 
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Fig. 11. Cardiomyocytes beating profile with contraction and relaxation information. (a) Raw 
data of cardiomyocytes beating profile. (b) Cardiomyocytes beating profile with contraction 
and relaxation peaks indicated (inset shows a single beat with contraction and relaxation peaks). 
 
Finally, the beating rate, beating period and frequency for cardiomyocytes contraction and 
relaxation can be measured based on the detected positive peaks that include contraction and 
relaxation peaks. In addition, the time between the cardiomyocytes contraction and the 
following relaxation can also be calculated with the detected peaks in Fig. 11(b). These 
measured data are given in Table 4. It is noted from Tables 1, 2, and 3 that the three methods 
can result in similar values for beating rate, beating period and frequency by using the same 
cardiomyocyte image sequence. 
 
Table 4. Measured Parameters on Cardiomyocyte Contraction and Relaxation Curve. 
Multi-parameters Values (mean/cv) 
Contraction 
Beating rate: 21.71/0 
Beating period: 2.93/(sd=0.08) 
Frequency 0.34/0 
Relaxation 
Beating rate: 20.84/0 
Beating period: 3.05/(sd=0.49) 
Frequency 0.32/0 
Time between contraction and the following relaxation 0.41/0.14 
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Fig. 12. Detected peaks based on four more cardiomyocyte sequences with the method in the 
Section 3.1. (a) Cardiomyocyte image sequences acquired with difficult conditions. (b), (c), and 
(d) "noise-free" recordings (i.e. no debris interfering with the measurement) similar to the 
previous recording.   
 
Four more cardiomyocyte image sequences were analyzed in order to show the generality of 
the proposed methods. Among these image sequences, one of them is acquired with difficult 
conditions which mean having severe disturbance (a few out-of-focus debris are flowing 
through the field of view during the acquisition) while the other sequences are comparable in 
quality to the one presented previously. Four image sequences with peaks detected using the 
first (Section 3.1), second (Section 3.2) and third (Section 3.3) methods are given in Fig. 12, 
Fig. 13 and Fig. 14 respectively where Fig. 12 (a), Fig. 13 (a) and Fig. 14 (a) are from image 
sequences under tough/difficult conditions. It should be noted from these figures that our 
proposed method can detect all of the peaks, even in image sequences with debris interference. 
However, we found that the first method generated many noisy peaks in difficult conditions 
(1st image sequence) which make the parameter measurement not accurate. On the other hand, 
the second and third methods are more stable to analyze these image sequences even those 
obtained under difficult conditions. Consequently, all of the needed multi-parameters can be 
measured based on these images, therefore proving the robustness of the analysis algorithm.  
Finally, the mean value of each of the parameter described in the first (Section 3. 1), second 
(Section 3. 2) and third (Section 3. 3) methods is measured based on all the five sequences 
used previously. The measured mean values for the three methods are given in Table 5, Table 
6, and Table 7, respectively.  
The combined measurements show the robustness of the proposed algorithm and how they 
allows quantify important cardiomyocyte dynamic parameters that can be used to screen 
compounds cytotoxic effects. The beating profile contains more information than can be 
obtained by electrophysiology or fluorescence imaging as it integrates the effect of all the ion-
channel involved and thus offer a signature that can be used to predict the effect of specific 
compounds. For instance inhibitors of hERG channel (the main class of channels assessed in 
cardio safety, which are involved in repolarization current) all results in a similar profile [7]. 
In addition, due to the non-invasive aspect of the measurements, both short-term and long-
term effects of the monitored compounds can be assessed with DHM. 
Table 5. Measured Values for Multiple Parameters on Cardiomyocytes Beating Profile on five sequences 
Multi-parameter Values (mean/cv) 
1: Amplitude: 0.85/1.50 
2: Rising time: 0.62/1.37 (seconds) 
3: Falling time: 0.85/0.99 (seconds) 
4: IBD50: 0.44/0.50 (seconds) 
5: IBD10: 2.44/0.45 (seconds) 
6: Rising/Falling slope: 0.51/1.52 
7: Beating rate: 71.14/0.81 
8: Beating period: 0.95/ (sd=0.84 seconds) 
9: Frequency 1.16/0.83 
Table 6. Measured Multiple Parameter on Cardiomyocyte Beating Profile on five sequences 
Multi-parameter Values (mean/cv) 
1: Amplitude: 40.01/1.21 
2: Rising time: 0.57/0.86 (seconds) 
3: Falling time: 0.43/1.13 (seconds) 
4: IBD50: 0.79/0.65 (seconds) 
5: IBD10: 2.35/0.38(seconds) 
6: Rising/Falling slope: 24.00/1.21 
7: Beating rate: 34.48/0.36 
8: Beating period: 1.98/(sd=0.83) 
9: Frequency 0.55/0.37 
 
 
Table 7. Measured Parameters on Cardiomyocyte Contraction and Relaxation Curve on five sequences. 
Multi-parameters Values (mean/cv) 
Contraction 
Beating rate: 28.52/0.16 
Beating period: 2.19/0.19 
Frequency 0.45/0.16 
Relaxation 
Beating rate: 28.52/0.17 
Beating period: 2.22/0.31 
Frequency: 0.45/0.18 
Time between contraction and the following relaxation 0.59/0.62 
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Fig. 13. Detected peaks based on four more cardiomyocyte sequences with the method in the 
Section 3.2. (a) cardiomyocyte image sequences acquired with difficult conditions. (b), (c), and 
(d) "noise-free" recordings (i.e. no debris interfering with the measurement) similar to the 
previous recording.    
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Fig. 14. Detected peaks based on four more cardiomyocyte sequences with the method in the 
Section 3.3. (a) cardiomyocyte image sequences acquired with difficult conditions. (b), (c), and 
(d) "noise-free" recordings (i.e. no debris interfering with the measurement) similar to the 
previous recording. 
 
4. Conclusions 
In this paper, for the first time, human cardiac muscle cells’ dynamics and their spontaneous 
beating rates are quantitatively explored through the fusion of digital holography microscopy 
and information processing algorithms. We demonstrate the suitability of DHM for 
monitoring and quantifying the beating function of cardiomyocytes and automatically 
measuring multiple parameters of cardiomyocytes based on the quantitative phase profiles 
acquired with DHM. The proposed method can be rapid, noninvasive and effective and allows 
for automated analysis between normal cardiomyocyte dynamics and all other abnormal 
activities. We believe that our automated non-invasive measurement procedures can open new 
perspectives for cardiotoxicological screening or profiling of candidate molecules in 
preclinical drug discovery and safety testing programs. 
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